Analytical Testing

Analytical excellence supporting every stage of drug development. From discovery to commercialization, SGS delivers rigorous, phase‑appropriate analytical testing to ensure product quality, safety, and regulatory readiness.

Download brochureContact us

SGS provides comprehensive analytical services that span the entire pharmaceutical development lifecycle—from early pre‑formulation through clinical release and commercial manufacturing. Our analytical scientists support small‑molecule and microbiome-based products with validated, phase‑appropriate methods that ensure robust decision‑making, regulatory compliance, and product quality.

End-to-end analytical support

Key Benefits

Seamlessly integrated analytical workflows from discovery through commercialization ensure consistent data quality and reduced development risk.

Phase-appropriate method development

Our experts build analytical methods that evolve with program needs—from early screening to full validation for clinical and regulatory submissions.

Advanced characterization capabilities  

State‑of‑the‑art techniques for impurity profiling, stability‑indicating methods, nitrosamine testing, elemental analysis, and extractable/leachable studies.

Expertise across all molecule types

Support for small molecules and microbiome APIs, including microbial purity, viability, and digital PCR analytics.

We provide critical support across all phases:

Discovery & Pre-clinical

  • Drug substance characterisation 
  • Formulation development analytical support
  • Method development & validation
  • Degradation & stability studies 

Review / Approve & Commercial Manufacture 

  • Process validation analytics 
  • Nitrosamines analysis
  • Elemental impurities
  • Extractables & leachables
  • Product life-cycle studies

Clinical Development

  • Raw material testing
  • Clinical stability testing
  • Comparator studies
  • Clinical release analytics 

Additionally, SGS offers specialized finished‑product analytics including stability‑indicating assays (HPLC/UPLC), dissolution and drug‑release profiling, impurity identification, chiral analysis, microbial purity, and dPCR for microbiome products.

CDMO ServicesOur FacilityAbout UsResources

Our Capabilities